account_id none on file
legal_name Co-Diagnostics, Inc.
ticker CODX
cik 1692415
domain co-dx.com
linkedin_company_url https://www.linkedin.com/company/codiagnostics-inc/posts/?feedView=all
entry_point_account_id none on file
name Co-Diagnostics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 1 filings 4 executives 5 family 0
why_nownone on file
calls
Sales and marketing expenses were $2.4 million compared to $4.5 million in 2024, primarily driven by lower personnel, consulting, and travel-related expenses.
Mar 31, 2026 / receipt, needs a key / Brian Brown, CFO | earnings call 2026-03-31 | transcript c54cffc9-36f8-4a12-adcc-61ca2439a1d0 | chars 14879-15037 | segment 14
filings
Global Expansion through Joint Ventures
ir_statement / Aug 25, 2026 / receipt
Kingdom of Saudi Arabia • Established October 2025 with Arabian Eagle
ir_statement / Aug 25, 2026 / receipt
KSA and 18 other MENA-region countries
ir_statement / Aug 25, 2026 / receipt
Reduce costs through technical innovation
ir_statement / Aug 25, 2026 / receipt
executives
| Brian Brown | CFO | receipt | |
| Dwight Egan | CEO | - | receipt |
| Edward L. Murphy | director | - | receipt |
| Eugene Durenard | director | - | receipt |
| Richard Abbott | President | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2024-03-15 | President, appointed | sec_8k |
| 2019-06-26 | director, appointed | sec_8k |
| 2019-06-26 | director, appointed | sec_8k |
mcp_package_hint
slug co-diagnostics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$